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Engineering red-emitting multi-functional nanocapsules for 
magnetic tumour targeting and imaging 
Julie Tzu-Wen Wang,*a Umberto Martino, a Rehan Khan, b Paul Southern, c Dönüş Tuncel, *b and 
Khuloud T. Al-Jamal *a 
In this work we describe the formulation and characterisation of red-emitting polymeric nanocapsules (NCs) incorporating 
superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic tumour targeting. The self-fluorescent oligomers were 
synthesised and chemically conjugated to PLGA which was confirmed by NMR, FT-IR spectroscopy and mass spectrometry. 
Hydrophobic SPIONs were synthesised through thermal decomposition and their magnetic and heating properties were 
assessed by SQUID magnetometry and calorimetric measurements, respectively. Magnetic nanocapsules (m-NC) were 
prepared by single emulsification/solvent evaporation method. The in vitro cytotoxicity was examined in CT26 colon 
cancer cells. The formulated fluorescent m-NCs showed good stability and biocompatibility both in vitro and in vivo in CT 
26 colon cancer models. Following intravenous injection, accumulation of m-NCs in tumour was observed by optical 
imaging. Higher iron content in the tumours exposed to magnetic field, compared to the contralateral tumours without 
the magnetic exposure in the same animal, further confirmed the magnetic tumour targeting in vivo. The overall results 
show that the engineered red-emitting m-NCs have a great potential as multifunctional nanocarriers for multi-model 
bioimaging and magnetic-targeted drug delivery.
Introduction 
Magnetic nanoparticles have been widely explored for their 
potential application for cancer diagnosis or therapy. 1, 2 For 
example, they can be used as contrast agents for magnetic 
resonance (MR) imaging to distinguish neoplastic lesions from 
normal tissues, taking advantage of their intrinsic magnetic 
properties. They can also be utilised for magnetic drug delivery 
such as tumour-targeting. Superparamagnetic iron oxide 
nanoparticles (SPIONs) are particularly ideal with this regard 
since they can be highly magnetised to the specific site of 
action upon exposure to external magnetic field and no 
magnetisation is retained once the magnetic field is removed, 
avoiding agglomeration. 3 SPIONs are usually produced as 
hydrophobic ferrofluid solution and need to be coated or 
encapsulated to be water-dispersible for intravenous injection. 
We have previously developed polymeric magnetic 
nanocapsules (m-NCs) capable of triple-modal imaging (i.e. 
MR, optical and nuclear imaging) 
. 4 NCs are nanoparticulate carriers composed of an oil core 
surrounded by a PEGylated-PLGA polymeric shell with 
lipophilic and/or hydrophilic surfactants present at the 
interface. These polymeric NCs served as a versatile platform 
with the capacity to load high amounts of water insoluble drug 
molecules/SPIONs/fluorescent probes into the oil core. 4-6 The 
polymeric formulation provided the protection against 
enzymatic degradation and conferred a greater 
physicochemical stability as a whole. Based on the enhanced 
permeability and retention (EPR) effect, the m-NCs were able 
to passively accumulate in solid tumours with leaky 
vasculature. 7, 8 The presence of SPION further facilitated 
magnetic targeting in tumours in mice when an external 
magnetic field was applied. 4, 7-9 As a result, with encapsulating 
an anticancer drug docetaxel, the m-NCs indeed significantly 
delayed tumour growth and reduced systemic side effects 
compared to the free drug. 9 
In previous studies, we were able to dynamically visualise 
magnetic targeting of m-NCs with tumour and its vasculature 
by optical imaging with the aid of infra-red fluorescent probes 
indocyanine green (ICG) 4 or 1,1-dioctadecyltetramethyl 
indotricarbocyanine Iodide (DiR) 7 incorporated into the oil 
phase of m-NC. Small organic fluorescent molecules can be 
used as imaging probes; however, they suffer from photo-
bleaching and are therefore not suitable for long time imaging, 
especially in vivo. Recently, intrinsically fluorescent polymers, 
capable of forming nanoparticulate systems, have been 
proposed as a new type of fluorophores which can be used for 
in vitro cell labelling, in vivo live imaging and in image-guided 
drug delivery. 10-14 It was also shown that drug molecules can 
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be loaded with high loading capacity due to hydrophobic effect 
and favourable - interaction between the drug molecules 
and the conjugated oligomer or polymer chains. 15, 16
Although conjugated polymer nanoparticles can provide high 
drug loading capacity, biodegradation of the large polymeric 
residues after the delivery can present some problems. To this 
end, conjugated oligomers are attractive because they have 
short chain and well-defined molecular weight. Moreover, 
they exhibit higher fluorescent quantum yield than their 
polymeric counterparts. 17, 18  However, one drawback is their 
lower drug loading capacity compared to polymer 
nanoparticles. Thus, in this work, we took a different approach 
and conjugated directly the carboxyl terminated PLGA to 
amine functionalised red-emitting fluorescent oligomer 
through amide bond formation. The formulation of m-NC with 
the encapsulation of SPIONs was optimised and characterised. 
The organ biodistribution profiles and ability for magnetic 
tumour targeting following intravenous injection were 
assessed in vivo in CT 26 colon cancer models by optical 
imaging and iron content quantification. The engineered self-
fluorescent m-NCs were capable of in vivo optical imaging and 
magnetic tumour targeting.
Results and discussion 
Synthesis and characterisation of Oligomer 1, Oligomer 2 and 
PLGA-Oligomer 
The main text of the article should appear here with headings 
as appropriate. In order to synthesise PLGA-conjugated 
oligomer, firstly Oligomer 1 and Oligomer 2 were synthesised 
as shown in the reaction Scheme 1. Monomer 1 (M1) and 
monomer 2 (M2) were prepared as reported previously 18 and 
subsequently bromide groups of M2 were substituted by 
azides to obtain M3. Thereafter, Pd-catalyzed Heck coupling 
reaction between M3 and 4,7-dibromobenzo[c]-1,2,5-
thiadiazole afforded Oligomer 1. In order to have suitable 
functional groups to link covalently with the carboxyl 
terminated PLGA, azide groups of Oligomer 1 were reduced to 
primary amine groups using PPh3 to provide Oligomer 2. 
Finally, PLGA was conjugated to Oligomer 2 through amide 
bond formation using DCC coupling reaction.
Due to the high molecular weight of PLGA (Av. MW, 18 kDa) 
compared to Oligomer 2 (MW, 745 Da), only one arm of the 
Oligomer 2 was functionalised. Unreacted Oligomer 2 and 
PLGA were removed by precipitating PLGA-Oligomer solution 
in THF into large excess of water-methanol mixture.
Monomers and oligomers were characterised fully, and their 
characterization data are provided in the supporting information 
(Figure 1 and S1-S3). Formation of Oligomer 1 and 2 were 
confirmed by NMR (Figure 1 and S2A), FT-IR spectroscopy (Figure 
S2C and S3A) and mass spectrometry (Figure S2B and S3A). In the 
IR-spectrum of Oligomer 1 (Figure S2C), the peak due to azide 
stretching at 2100 cm-1 disappears upon reduction of azide groups 
into amines to form Oligomer 2 (Figure S3A). Figure 1 compares the 
1H-NMR spectra of Oligomer 1, Oligomer 2 and PLGA-Oligomer.  1H-
NMR spectrum of PLGA-Oligomer shows the peaks of PLGA protons 
and some peaks from the aliphatic protons of Oligomer 2. The 
peaks belong to aromatic protons of Oligomer 2 are not clearly seen 






























R1 = R2, R3, R4= H
Scheme 1: Synthesis scheme for PLGA-Oligomer. (a) M1: 1,3-Dibromopropane, aq. NaOH (50%, w/w), tetra-butyl ammonium bromide (TBAB), 80 °C, 64%, 
(b) M2: tributyl vinyltin, Pd(Cl2)(PPh3)2, 2,6-di-tert-butyl phenol, toluene, 100 °C, 24 h, 90%, (c) M3: NaN3,  60 °C, DMF, 24 h, 93%, (d) aq. K2CO3, Pd(OAc)2, 
Pd(PPh3)4, DMF, 70 °C, 24 h, 45%, (e) PPh3, THF, 25 °C, 24 h, 80%, (f) 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), 4-dimethylaminopyridine 
(DMAP), 60 °C, DMF, 48 h, 78%.
Figure 1: 1H-NMR (400 MHz, CDCl3, 25oC) spectra of Oligomer 1, 2 and 
PLGA-Oligomer.
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could be due to a decrease in the mobility of aromatic backbone of 
the Oligomer 2 caused by the attachment of a bulky PLGA arm.
SPION synthesis and characterisation 
SPIONs were synthesised through a high-temperature organic 
phase decomposition of an iron precursor. 19, 20 In contrast to the 
widely used co-precipitation method pioneered by Massart et al. 
with reactions taken place at room temperature, 21 the high-
temperature decomposition method was reported to be able to 
provide a greater control on the final size of nanoparticles with a 
narrower size distribution. 22 Carrying out nucleation at 200 °C and 
grown reaction under reflux at ~300°C separately is the key to yield 
monodisperse and highly crystalline magnetic nanoparticles. In the 
present study, different durations for nucleation and growth (30 
min to 2 h) were applied to optimise the synthesis of Fe3O4 
magnetic nanoparticles (NP1 – NP5, Table S1). By SQUID 
(superconducting quantum interference device) magnetometry, the 
obtained hysteresis loops normalised by saturation magnetisation 
were identical among all NPs, indicating that varying the time of 
nucleation and growth did not significantly affect the magnetic 
properties of the synthesised Fe3O4 NPs significantly (Figure S4A). 
The heating capability of the magnetic nanoparticles can be 
assessed by quantification of the intrinsic loss power (ILP) values, 
the normalised energy dissipation rates, facilitating direct 
comparison when measurements were performed under different 
conditions. 23 Typical ILP values for iron oxide nanoparticles were 
reported in the range from 0.17 to 3.12 nHm2/kg 24 or below 5 
nHm2/kg. 25 The obtained ILP values (Figure S4B, and Table S1) were 
relatively low (0.02-0.04 nHm2/kg) as expected due to small particle 
size, estimated smaller than 10 nm. 26 Thermogravimetric analysis 
(TGA) was carried out to measure the oleic acid coating on NP1-NP5 
which is indicated as weight loss % shown in Table S1. It has been 
reported that the amount of surfactant adsorption on the Fe3O4 
nanoparticles decreased when the size of nanoparticles increased. 
20 Since NP1 exhibited the lowest weight loss and the highest ILP 
value among all, further seed mediated growth (SMG) reaction (see 
Methods), known to increase the diameter of nanoparticles by ~2 
nm per cycle, 19 was performed on NP 1 to increase SPIONs size and 
presumably their heating ability. The same synthesis condition (i.e. 
nucleation for 1 h and growth for 30 min) was followed for SMG 
reaction. For comparison, a parallel approach was carried out to 
produce Fe/Co hybrid nanoparticles in a single step method which 
is expected to have enhanced heating property due to increased 
magnetic anisotropy. 27
NP 1 is named SPION 1 hereafter and SPION 2-3 were prepared by 
subjecting NP 1 to further 1-2 cycles of SMG respectively. The 
magnetic and heating properties of SPION 1-3 and the hybrid SPION 
Fe/Co were assessed (Figure 2). No shift in hysteresis was present, 
indicating that their superparamagnetic behaviours were 
maintained, and their sizes are under the 
superparamagnetic/ferromagnetic threshold (Figure 2A). SPIONs 
produced by SMG exhibited significantly higher ILP values (0.271 
and 0.533 nHm2/kg for SPION 2 and SPION 3, respectively) than 
SPION 1 (0.043 nHm2/kg) and the hybrid SPION Fe/Co (0.178 
nHm2/kg) (Table 1). Since its ILP value fell into the range reported in 
the literature, SPION 3 was chosen to formulate the magnetic 
polymeric nanocapsules in the subsequent studies.
PLGA nanocapsules formulation and characterisation 
Nanocapsules were formulated by the emulsification/solvent 
evaporation method. Initial formulation was optimised using PLGA 
mixing with increasing amount of PLGA-Oligomer (10, 20 and 50 % 
of total polymer). The results of the size and zeta potential 
measurements of formulated nanocapsules are shown in Table S2. 
It was found that increasing the percentage of PLGA-Oligomer led 
to increased particle size and surface charge (less negative) and the 
nanocapsules made of 50 % PLGA-Oligomer was the largest in size 
(>300 nm) among the three nanocapsules. Nevertheless, all 
formulations showed good stability in which no significant changes 
in size and zeta potential were observed after storage at 4 °C for 1 
week (data not shown). After purification by using PD-10 columns, 
tetrahydrofuran was added to the collected nanocapsules to break 
down the particles and dissolve the polymers. The optical 
properties of NC, Oligomer 2 and PLGA-Oligomer were assessed by 
UV-Vis spectroscopy and fluorimetry (Figure S5). It should be noted 
that NC were dispersed in PBS, while Oligomer 2 and PLGA-
Oligomer were dissolved in THF. From the fluorescence spectra 
(Figure 5SB), Oligomer 2 and PLGA-Oligomer displayed the same 
emission maximum at 580 nm and there was a red shit for NC with 
the emission maximum at 590 nm. By measuring the fluorescence 
intensity of the PLGA-Oligomer extracted from nanocapsules 
(calibration curves shown in Figure S5C), nearly 100 % recovery was 
obtained in the polymer solutions, indicating that entire amount of 
Table 1: Heating properties of SPIONs
SPIONs Intrinsic loss power (ILP, nHm2/kg) a




a The calculation of ILP values were based on the iron content measured 
by ICP-MS and did not account for the oleic acid coating. The values 
were therefore lower than the actual values.
Figure 2: Characterisation of the SPIONs synthesised by seed 
mediated growth reacti n (SMG) and SPION hybrid Fe/Co. (A) 
Magnetic property and (B) heating capacity assessments. 
Magnetization hysteresis curves were measured by SQUID 
magnetometry and normalised by the weight of the magnetic 
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PLGA-Oligomer was incorporated into the nanocapsule 
formulations (data not shown). Nanocapsules composed of 20 % 
PLGA-Oligomer 
of total polymers, with compromised properties in terms of size, 
stability and fluorescence intensity, were chosen for further PLGA-
PEG magnetic nanocapsule formulation.
Magnetic PLGA-PEG nanocapsules formulation and 
characterisation
Magnetic polymeric nanocapsules consisted of PLGA-PEG (80 %), 
PLGA-Oligomer (20%) and SPION 3 were formulated using the 
emulsification/solvent evaporation method. The formulated 
nanocapsules are named m-NC hereafter. The counterpart 
formulation without SPIONs was also formulated, named NC 
hereafter. The composition, size and zeta potential measurements 
of NC and m-NC are shown in Table 2. Inclusion of SPIONs slightly 
increased the size but does not affect the zeta potential of the 
nanocapsules. The size of NC and m-NC was in the range of 230-250 
nm, larger than the m-NC reported in our previous study  (~200 nm) 
. 4 High encapsulation efficiency (EE %) of SPIONs was determined 
by ICP-MS in which nearly ~90 % SPION EE% was achieved.
In vitro cytotoxicity studies 
The cytotoxic effect of NC and m-NC was assessed in CT26 cells 
using MTT assay prior to in vivo studies. As expected from our 
previous study, 9 no significant toxicity was observed in cells treated 
with either NC or m-NC up to the polymer concentration of 100 
µg/ml for 72 h.
In vivo optical imaging with magnetic targeting
For in vivo studies, NC and m-NC solutions were concentrated to 10 
x and buffered with 10X PBS for injection. Physicochemical 
characterisation showed the size of NC or m-NC was within the 
range of 210-240 nm (Table S3). Prior to in vivo imaging, the optical 
properties of NC and m-NC solutions were tested on a well plate at 
different concentrations up to 500 µg/ml using IVIS Lumina III 
optical imaging system. This was performed considering that the 
previously reported oligomer has never been used for in vivo 
imaging. 18 A linear regression was measured for both NC and m-NC 
solutions at 500 nm/620 nm as excitation/ emission wavelength. 
Expectedly, due to the presence of SPIONs, quenching of 
fluorescence was observed in m-NC as signals were lower compared 
to NC at the same polymer concentration which was more obvious 
at the higher concentrations (Figure S6). 
CT26 tumour-bearing balb/c mice were intravenously injected with 
NC or m-NC. A permanent magnet (0.515 T) was placed at one side 
of the tumours (TU+) for 1 h. The contra-lateral tumour (TU-) was 
Table 2: Physicochemical characterisation of different formulations of fluorescent NC and m-NCs prepared by the emulsification/solvent 
evaporation method.







NC 80% 20% 236.3 ± 4.8 0.208 -13.9 ± 1.2 -
m-NC 80% 20% 2.5 mg 251.1 ± 3.8 0.221 -13.2 ± 0.2 89.3
* Measurements were performed by dynamic light scattering in 10 mM NaCl (n=3).
† Iron content was determined by ICP-MS (n=3)





























Figure 3: In vitro cytotoxicity assessments. CT26 cells were incubated with 
NC, and m-NC at the polymer concentration of 10, 50 and 100 µg/ml. Cell 
viability was assessed by MTT assay after 72 h incubation.
Figure 4: In vivo whole-body optical imaging and ex vivo biodistribution of 
NC and m-NC in CT26 tumour-bearing Balb/c mice after intravenous 
administration. (A) Representative whole-body images from dorsal views of 
mice at 1, 4 and 24 h post injection. (B) Representative ex vivo images of 
tissues excised at 24 h post injection. (C) Semi-quantitative analysis of 
uptake of NC and m-NCs in major tissues at 24 h post injection. Balb/c mice 
were transplanted subcutaneously with CT26 tumours at the lower flanks. 
When tumours reached ~7-8 mm in diameter, mice were i.v. injected with 
NC or m-NC (250 mg polymer/kg and 50 mg SPION/kg). Magnetic field was 
applied by placing a permanent magnet (0.515 T) at the tumour on the left 
side (TU+) for 1 h (pointed by arrows). All images were obtained by IVIS 
Lumina III optical imaging system (λex: 500; λem: 620 nm). Data were 
analyzed by Living Image® 4.3.1 Service Pack 2 software. Data present as 
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used as an internal control where no magnet was applied. Animals 
behaved normally without weight changes up to 24 h after 
receiving single intravenous injection of NC or m-NC. Increasing 
signals in tumours were observed over time up to 24 h although 
differences between TU+ and TU- were not obvious through whole-
body imaging (Figure 4A). Ex vivo images of tissues excised at 24 h 
post injection confirmed the uptake of NC and m-NC in tumours 
(Figure 4B and S7). NC and m-NC had similar biodistribution 
patterns in general in which the particles accumulate in liver as well 
as other organs such as spleen, lung, kidney and intestine/colon. 
Quantitative analysis showed higher but insignificant signals 
detected in the tumours that had received 1 h magnet exposure 
(TU+) compared to non-treated tumours (TU-) in both cases of mice 
injected with NC or m-NC (Figure 4C). Decreased fluorescence for 
m-NC compared to NC group was observed, more significantly for 
TU+ treatment (p =0.01). This suggested the possibility of false 
negative results due to fluorescence quenching of the oligomer by 
SPION. It was deemed necessary to verify magnetic targeting by 
another method based on quantification of SPION by ICP-MS.
Quantification of the iron content in tissues by ICP-MS
ICP-MS analysis of iron content in tissues was further performed to 
assess the magnetic targeting in tumours considering that 
fluorescence of the oligomer was significantly quenched by SPION. 
Samples from naïve mice was also processed to obtain the intrinsic 
iron levels in these tissues. Figure 5 presents the iron content per g 
of tissues. In the mice injected with m-NC, the highest amount of 
iron was detected in spleen and liver which already contains the 
highest intrinsic iron (black bars). The intrinsic amount of iron in 
CT26 tumours were low (32.8 µg Fe/g of tumour) whilst a significant 
increase was observed in the tumours from mice injected with m-
NC (zoom-in graph, Figure 5). Moreover, the tumours exposed to 
magnet for 1 h (TU+) showed a significantly higher iron content than 
the tumours without magnet (TU-) (507.6 ± 6.7 vs 362.0 ± 41.9 µg 
Fe/g, p=0.04). The results indicate the magnetic targeting effects on 
increasing the tumour uptake of m-NC. The fact m-NC reached 
tumour and achieved magnetic targeting with increased tumour 
uptake also suggest m-NC was stable enough in vivo after 
intravenous injection.
The multifunctional features of SPIONs have shown great 
promise in a wide range of biomedical applications. Moreover, 
many SPION-based nanoconstructs have been developed in 
which SPIONs were encapsulated or integrated with other 
materials to improve their hydrophilicity and biocompatibility. 
28, 29 The present study demonstrated an effective and robust 
approach to encapsulate high amount of hydrophobic SPIONs 
in the hydrophobic compartment of the polymeric emulsion. 
The NC and m-NC developed in this study share many common 
features with the NC formulations published in our previous 
studies. 4, 7, 9 Apart from the inclusion of fluorescent PLGA-Oligomer 
and the replacement of SPIONs with the heating property, the 
choice of other excipients (e.g. PLGA-PEG, oil, surfactant), the 
quantities, and the formulation method and parameters were 
intended to remain unchanged to inherit the excellent fundamental 
physiochemical properties and the favourable in vivo behaviours. 
Indeed, the resulting NC/m-NC exhibit typical characteristics for 
coil-cored PEGylated NC including good colloidal stability, high 
SPION loading, and prolonged blood circulation thus passively 
enhanced tumour uptake. The resulting stable magnetic 
nanocapsules indeed exhibited improved water dispersity, 
prolonged blood circulation, and little or no toxicity in vitro 
and in vivo which are inherited from the characteristics of the 
PLGA-PEG polymers. By substitution of 20 % PLGA-PEG 
polymers with the red-emitting macromolecule conjugate 
consisting of an oligomer backbone with PLGA polymer chains, 
the engineered self-luminescent NCs and m-NCs enabled 
direct visualisation of their kinetic tumour accumulation over 
time after administration by in vivo optical imaging. This is 
different from our previous studies using conventional 
approaches either encapsulating or labelling with fluorescent 
probes for NC/m-NC in which the labelling stability and 
dissociation of the dye from the nanocarriers should be taken 
into account while assessing biodistribution profiles by 
imaging. 4, 7 Autofluorescence from tissues are expected which 
is mainly in green and red regions if excited by blue light. 
Considering the excitation for the fluorescent NC and m-NC at 
500 nm (blue light), the obtained emission signals at 620 nm 
were rather satisfactory. In fact, the pilot in silico imaging in a 
well-plate has indirectly predicted the capability of the 
formulated m-NC for in vivo detection. The highest dose tested 
in the well-plate (500 µg/ml) was equivalent to 1 % injection 
dose (ID) for the in vivo studies (i.e. 1 % ID contains 50 µg of 
polymer) whose signals of 1x1010 photos/sec were distinct 
from background fluorescence and the likelihood of tissue 
autofluorescence signals usually below 109 photos/sec (Figure 
S6). The fluorescent PLGA-Oligomer and its nanocapsule 
formulation seemed to exhibit relatively high signal-to-noise 
ratio, indicating the capability for optical imaging in vivo or in 
clinic.
Hyperthermia is a promising tumour treatment and studies 
have developed magnetic nanoparticles for hyperthermia by 
means of photothermal ablation agent when irradiated with a 
NIR laser 30 or induce magnetic hyperthermia in the presence 
of an alternating magnetic field. 31 The SPIONs synthesised in 
Figure 5: ICP-MS analysis of SPION uptake in CT26 tumour-bearing mice 
treated with m-NC. CT26-bearing Balb/c mice were i.v. injected m-NC (250 
mg polymer/kg and 50 mg SPION/kg) and a permanent magnet (0.515 T) 
was applied to the tumour on one side (TU+) but not the other (TU-) for 1 h. 
At 24 h post injection, major organs and tumours were excised and 
proceeded with ICP-MS analysis as described in Methods. The data are 
expressed as iron content per g of tissues (dried weight) as mean±S.D. (n=3). 
*p = 0.04 (one-way ANOVA).
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the present study displayed desirable heating properties, the 
evident magnetic tumour targeting has opened up a feasible 
future application of the developed m-NCs as a hyperthermia 
agent.
Conclusions
In conclusion, the resultant fluorescent m-NCs showed 
desirable magnetic and heating properties and exhibited good 
stability and biocompatibility both in vitro and in vivo. 
Following intravenous injection, accumulation of m-NCs in 
tumour was observed by optical imaging. Higher iron content 
in the tumours exposed to magnetic field, compared to the 
contralateral tumours without the magnetic exposure in the 
same animal, further confirmed the magnetic tumour 
targeting in vivo. The developed red-emitting functionalised m-
NCs have a great potential as image-guided delivery system 
capable of magnetic-induced heating. Evaluation on the ability 
of the developed m-NC for hyperthermia and encapsulation 
chemotherapeutic drug will be the next stage studies.
Experimental
Materials 
All the chemicals used were analytical grade, obtained from 
commercial suppliers and used as received without further 
purification. D/L-lactide/glycolide copolymer 75/25 (PLGA18KDa-
COOH) was purchased from Purac Biomaterials (Netherlands). 
Soybean lecithin (Epikuron 140 V) was a kind gift from Cargill 
Pharmaceuticals (USA). D/L-lactide/glycolide copolymer 75/25 
(PLGA18KDa-COOH) was purchased from Corbion Biomaterials 
(PURASORB® products, the Netherlands).  PLGA-NH-PEG was 
synthesised as previously described 5. Tween® 80 was obtained 
from Fisher Scientific Ltd (UK). Iron(III) acetylacetonate, 
Cobalt(II) avetylacetonate, 1,2 tetradecanediole, oleylammine, 
oleic acid, sodium chloride, castor oil, toluene, and benzyl 
ether were purchased from Sigma-Aldrich (UK). Black 96 well-
plates were purchased from Fisher Scientific Ltd (UK). 
Disposable polystyrene cuvettes (for size and PDI) or capillary 
cells (for zeta potential) (Malvern Instrument, UK). PD-10 
desalting column was obtained from GE Healthcare Life 
Sciences (UK). Gibco cell culture reagents including RPMI-1640 
medium, fetal bovine serum (FBS), GlutamaxTM, non-essential 
amino acids, penicillin/streptomycin, Trypsin/EDTA, phosphate 
buffered saline (PBS) were purchased from Thermo Fisher 
Scientific Inc. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) was purchased from 
Sigma-Aldrich (UK).
Synthesis of 9,9-bis(3-azidopropyl)-2-vinyl-9H-fluorene (M3)
2-bromo-9,9-bis(3-bromopropyl)-9H-fluorene and (M1) 9,9-bis(3-
bromopropyl)-2-vinyl-9H-fluorene (M2) were synthesized as 
reported previously. 18  NaN3 (400 mg, 6.15 mmol) was suspended 
in 10 mL of DMSO in round bottom flask and 9,9-bis(3-
bromopropyl)-2-vinyl-9H-fluorene (M2) (600 mg, 1.38 mmol) was 
added into the flask. The reaction mixture was stirred at 60 C for 
24 h. After completion of the reaction, the solvent was removed 
under reduced pressure. The residue was washed with water 
several times and the collected solid was dried under reduced 
pressure. Yield: 460 mg, 93%. 1H NMR (400 MHz, CDCl3, 25 oC) δ 
ppm: 0.88-0.96 (m, 4H), 2.11-2.15 (t, 4H), 2.98-3.02 (t, 4H), 5.30-
5.32 (d, 1H), 5.81-5.86 (d, 1H), 6.79-6.86 (m, 1H), 7.35-7.73 (m, 7H).
Synthesis of Oligomer 1
9,9-bis(3-azidopropyl)-2-vinyl-9H-fluorene (516 mg, 1.44 mmol) and 
4,7-dibromobenzo[c][1,2,5]thiadiazole (207 mg, 0.72 mmol) were 
placed in a two-neck round bottom flask and dried under vacuum 
for 30 min. 10 mL dry and degassed dimethylformamide (DMF) was 
added and stirred to complete dissolution. Aqueous solution of 
K2CO3 (486 mg, 3.51 mmol) was added into the flask. The mixture 
was subjected to freeze-thaw-pump cycle for 3 times to remove 
oxygen. Catalytic amount of Pd(OAc)2 (25.3 mg, 0.11 mmol) and 
Pd(PPh3)4 (26 mg, 0.02 mmol) were added under N2 flow and the 
reaction mixture was heated to 70 °C for 24 h while constant 
stirring and under N2 flow. After completion of the reaction, the 
solvent was removed under reduced pressure. The crude product 
was dissolved in dichloromethane (DCM) and extracted with water 
for several times. The organic phase was dried and further purified 
by column chromatography using diethyl ether as an eluent. Yield: 
423 mg, 45 %. 1H NMR (400 MHz, CDCl3, 25 oC) δ ppm: 0.87-1.00 (m, 
8H), 2.08-2.13 (m, 8H), 2.97-3.05 (d, 8H), 7.00-7.87 (m, 20H). 13C 
NMR (400 MHz, CDCl3, 25 °C) δ ppm: 23, 30, 38, 52, 54, 119, 120, 
120.53, 121, 122, 123, 124, 126, 127, 128, 129.12, 134.1, 138, 141, 
142, 149, 160. ESI-MS (m/z): Calcd. for C48H44N14S [M+H]+ 
:849.36, found: 849.36.
Synthesis of Oligomer 2
Oligomer 1 (200 mg, 0.236 mmol) was dissolved in tetrahydrofuran 
(THF) (10 mL) and then the solution of PPh3 (370 mg, 1.48 mmol) in 
THF (5 mL) was added. The resulting mixture was stirred for 24 h at 
room temperature. Water (10 mL) was then added and stirred for 
24 h. THF was removed under reduced pressure and the 
precipitates were collected by filtration. The solid was washed with 
diethyl ether several times and then dried under reduced pressure. 
Yield: 140 mg, 80%. 1H NMR (400 MHz, CDCl3, 25 oC) δ ppm: 0.87-
1.00 (m, 8H), 1.5-1.8 (m, 8H), 2.5 (m, 8H), 7.00-7.87 (m, 20H). ESI-
MS (m/z): Calcd. for C48H52N6S [M+H]+ :745.40, found: 745.40
Synthesis of PLGA-Oligomer
Oligomer 2 (70 mg, 0.094 mmol) was dissolved in dry DMF (6 mL) 
and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (73 mg, 
0.47 mmol) and 4-dimethylaminopyridine (DMAP) (29 mg, 0.24 
mmol) were added. The mixture was stirred for 5 min before adding 
PLGA (300 mg). The resulting mixture was further stirred at 60 C 
under N2 (g) for 48 h. After the reaction was over, the solvent was 
removed under reduced pressure and the residue was washed with 
water several times and then dried in the vacuo. Yield: 290 mg, 
78%.
NMR, LC-MS and UV-Vis characterisations and instrumentation 
All 1H and 13C NMR spectra were recorded at room temperature 
using a Bruker Avance III 400 MHz NMR spectrometer. CDCl3 
purchased from Merck was used as NMR solvent. Chemical shifts 
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are reported in ppm. Mass analyses were done with Agilent 6210 
LC/MS TOF mass spectrometer. Optical characterizations were 
performed by Cary 300 UV-Vis spectrophotometer and Cary Eclipse 
fluorescence spectrophotometer.
SPIONs synthesis
The synthesis of SPIONs was performed by an high-
temperature degradation of Iron(III) acetylacetonate as 
reported in literature. 19, 20 Fe(acac)3 (2 mmol), 1,2-
tetradecanediol (10 mmol), oleic acid (6 mmol), oleylamine (6 
mmol), and benzyl ether (20 mL) were mixed and magnetically 
stirred under N2 flow. For the synthesis of NP1, the mixture 
was heated to 200 °C for 1 h (nucleation reaction) and then, 
under a blanket of nitrogen, heated to reflux (298 °C, grown 
reaction) for another 30 min. The black-brown mixture was 
cooled to room temperature by removing the heat source.  
After the thermo-degradation reaction under ambient 
conditions, ethanol (40 mL) was added to the mixture and 
monodisperse Fe3O4 nanoparticles were obtained after 
centrifugation. The retrieved Fe3O4 nanoparticles were 
dissolved in hexane in the presence of oleic acid (∼0.05 mL) 
and oleylamine (∼0.05 mL). Centrifugation (6000 rpm, 10 min) 
was applied to remove any undispersed residue. The product, 
oleic acid-capped Fe3O4 nanoparticles, was then precipitated 
with ethanol, centrifuged (6000 rpm, 10 min) to remove the 
solvent, and re-dispersed into hexane, yielding NP1 (SPION 1). 
Different nucleation and grown time were used to synthesise 
NP2-NP5 in which the details are described in Table S1. SPION 
1 dispersed in hexane was used as the seed to grow larger 
SPIONs in the Fe(acac)3 precursors solution. Following the 
same workup procedures (e.g. nucleation/growth reaction and 
purification) described above, bigger oleic acid-capped Fe3O4 
nanoparticles, i.e. SPION 2 (2 SMG steps) and SPION 3 (3 SMG 
steps), were produced. 
As a control, reaction of Co(acac)2 and Fe(acac)3 (molar ratio 
Co(acac)2 : Fe(acac)3 was 1 : 4; 2 mM total metal salts) 
underwent 2 h nucleation and 1 h growth reaction, leading to 
hybrid CoFe2O4 nanoparticles which was also dispersed in 
hexane.
Superconducting quantum interference device (SQUID) 
magnetometry 
The magnetic properties of the SPIONs were assessed by SQUID 
magnetometry. SPION samples (approx. 10 mg) were mounted 
using soft gelatin capsules and the magnetization curves were 
recorded at room temperature (300K) using a Quantum Design (San 
Diego, USA) MPMS-VSM between ± 7 Tesla.
Thermogravimetric Analysis (TGA) 
The amount of oleic acid coating on the SPION was 
characterised by the thermogravimetric analysis (TGA) using 
TGA Q500 (TA instrument). About 10 mg of SPIONs was loaded 
into platinum pan and the measurement was pre-equilibrated 
at 80 °C and then heated from 100 °C to 800°C with a 
temperature ramp of 10 °C/min under compressed air 
atmosphere with balance and sample purge flow at 10 and 90 
ml/min, respectively.
Heating capability measurement
Calorimetric measurements were made using a radio 
frequency amplifier (Thamway T162-5723B) with a frequency 
range of 500–1000 kHz. The resonant circuit further consisted 
of a 20-turn water-cooled solenoid with 8cm diameter. The 
maximum AC magnetic field amplitude that could be 
generated was 13 kA/m at 930 KHz. A round-bottom-shaped 
plastic sample holder was used and surrounded by layers of 
insulation to protect the sample against ambient heating from 
the coil. Temperature measurements were conducted with 
fibre-optic temperature probes.23
 
NC and m-NC formulation 
NCs and m-NCs were synthesised by the single 
emulsification/solvent evaporation method. Briefly, PLGA-PEG 
and PLGA-Oligomer mixture (12.5 mg), castor oil (75 mg), 
soybean lecithin (25 mg) and SPIONs (2.5 mg) were dissolved 
in 2.5 ml dichloromethane. Different ratios of PLGA-PEG and 
PLGA-Oligomer (weight percentage 90 %:10 %, 80 %:20 % and 
50 %:50 %, Table S2) were used to formulate m-NC. The 
organic phase was poured into an aqueous phase (5 ml, water) 
containing Tween® 80 (20 mg). The resultant dispersion was 
emulsified by ultra-sonication using a probe sonicator 
(Soniprep 150, UK) at 15 micro amplitude for 180 s in an ice 
bath, followed by organic phase evaporation in a chemical 
fume hood under stirring for 20 min. The formulated NCs and 
m-NC were purified by size-exclusion chromatography (PD-10 
column) using deionised water as the eluent to remove any 
un-encapsulated SPION or materials that are lacking water 
solubility. The final volume of the NC and m-NC solutions was 
adjusted to 5 ml using a rotary evaporator at 40 °C.
 
Size and zeta measurements 
The hydrodynamic size (Z-Average), polydispersity index (PDI) 
and Zeta potential of the formulated NCs and m-NCs were 
determined by NanoZS (Malvern Instrument, UK) using 
disposable square polystyrene cuvettes (Malvern Instrument, 
UK) for size and PDI, and disposable capillary cells (Malvern 
Instrument, UK) for Zeta potential at 25 °C. For size 
measurement, NC and m-NC solutions were diluted with 
deionised water or 10 mM NaCl. The Z-Average diameter and 
polydispersity index were presented as the average value of 
three measurements, with 15 runs within each measurement. 
Electrophoretic mobility was used to calculate the Zeta 
potential measurement. Three measurements were performed 
with 10-20 runs within each measurement.
SPION encapsulation efficiency measurements
The iron content in the hydrophobic SPIONs stock solutions 
and the SPION encapsulated in m-NCs were determined by 
inductively couple plasma mass spectrometry (ICP-MS) (Perkin 
Elmer SCIEX ICP mass spectrometer, ELAN DRC 6100, USA). Fe 
standards (Leeman Labs Inc., MA) were prepared in 20 % nitric 
acid to obtain a standard curve in the range of 10-10000 parts 
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per billion with respect to Fe. Different concentrations of 
SPION and m-NC solutions were digested in 67% nitric acid and 
incubated overnight at 50 °C. The resulting solution was 
diluted with deionised water before measurement. Iron 
content in non-purified NC solutions and purified NC solutions 
was measured to calculate the SPION encapsulation efficiency 
(EE%) in m-NCs.
In vitro cytotoxicity
CT26 murine colon carcinoma (CT26, ATCC®, CRL-2638TM) 
cells were cultured in RPMI-1640 medium supplemented with 
10% FBS, 50 U/mL penicillin, 50 μg/mL streptomycin, 1 % 
GlutamaxTM and 1 % non-essential amino acids. Cells were 
routinely grown in 75 cm2 canted-neck tissue culture flasks 
and passaged twice a week using Trypsin/EDTA at 80 % 
confluency. 
CT26 cells were seeded in 96-well plates and incubated with 
NC or m-NC in complete media in the concentration of 
polymer at 10, 50 and 100 µg/mL for 72 h. Cell viability was 
examined by MTT assay. Briefly, the culture medium was 
removed and replaced with 120 μL of MTT solution (at a 
concentration of 5 mg/mL in PBS with a further 1: 6 dilution in 
media prior to use). Cells were incubated further for 3 h. 
Medium was removed, and the formed formazan was 
solubilised in 200 μL of DMSO. The absorbance was read at 
570 nm using a FLUO star OPTIMA plate reader (BMG 
Labtech). cell viability was calculated as a percentage of 
untreated control cells and expressed as mean ± S.D. (n=6).
Animals and the tumour model
All animal experiments were performed in compliance with 
the UK Animals (Scientific Procedures) Act 1986 and UK Home 
Office Code of Practice for the Housing and Care of Animals 
Used in Scientific Procedures (Home Office 1989). In vivo 
experimentation was adhered to the project licence approved 
by the King’s College London animal welfare and ethical review 
body (AWERB) and UK Home Office. Female Balb/c mice aged 
4-6 weeks were purchased from Envigo (UK) and used for all 
the in vivo experiments. CT26 cells were cultured as described 
above. Cells were harvested, resuspended in PBS and injected 
subcutaneously at the lower flanks of both sides of the mice. 
Purified NC and m-NC solutions were further concentrated by 
10 times using a rotary evaporator and were adjusted to 
become isotonic by adding 10x PBS buffer solution. Disk 
neodymium magnets (8 mm in diameter, first4magnet, UK) 
with surface magnetic field flux densities at 0.515 Tesla (0.5 T) 
were used for in vivo magnetic targeting studies.
 
In vivo optical imaging and organ biodistribution studies
Biodistribution studies were carried out when the tumours 
reached an appropriate size (~7-8 mm in diameter). CT26-
bearing mice were subcutaneously injected with NC or m-NC 
solutions (250 mg polymer/kg and 50 mg SPION/kg). 
Immediately after injection, one magnet was placed non-
invasively over the surface of the tumour implanted on the left 
flank and retained using surgical tapes. The contralateral 
tumour on the right side was used as an internal negative 
control where no magnet was applied. The magnet was 
removed at 1 h post-injection of the NC or m-NCs. Optical 
imaging was performed using an IVIS® Lumina series III In Vivo 
Imaging Device (Caliper Life Sciences, Perkin Elmer, USA). 
Images of mice were captured at 1, 4 and 24 h post-injection. 
At 24 h post-injection, major organs (brain, heart, lung, liver, 
spleen, kidney, intestine/colon) and tumours were excised, 
weighed and imaged by IVIS Lumina III optical imaging system 
(500/620 nm excitation/emission wavelengths) to assess the 
accumulation in tissues semi-quantitatively.
The iron accumulation in tissues were assessed quantitatively 
using ICP-MS. Tissues were dried, weighed and digested in 67 
% nitric acid and incubated overnight at 50 °C. The digested 
tissue solutions were diluted with deionised water and 
centrifuged at 4,000 × g for 30 min. The supernatants were 
transferred into new tubes for ICP-MS analysis described 
previously. 
Statistics analysis
Statistical significance between groups was determined using 
one-way ANOVA. Differences were considered statistically 
significant when p-values were less than 0.05.
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